D. Vurallı Bakkaloğlu Et Al. , "The incidence and prognostic impact of ASXL1 mutation protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing and immunohistochemistry," XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology , Cologne, Germany, pp.125, 2016
Vurallı Bakkaloğlu, D. Et Al. 2016. The incidence and prognostic impact of ASXL1 mutation protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing and immunohistochemistry. XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology , (Cologne, Germany), 125.
Vurallı Bakkaloğlu, D., ŞENTÜRK ÇİFTÇİ, H., Müslümanoğlu, H., EKİZOĞLU, S., ÇINAR, Ç., AR, C., ... TÜZÜNER TUNÇAY, N. N.(2016). The incidence and prognostic impact of ASXL1 mutation protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing and immunohistochemistry . XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology (pp.125). Cologne, Germany
Vurallı Bakkaloğlu, Doğu Et Al. "The incidence and prognostic impact of ASXL1 mutation protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing and immunohistochemistry," XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology, Cologne, Germany, 2016
Vurallı Bakkaloğlu, Doğu V. Et Al. "The incidence and prognostic impact of ASXL1 mutation protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing and immunohistochemistry." XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology , Cologne, Germany, pp.125, 2016
Vurallı Bakkaloğlu, D. Et Al. (2016) . "The incidence and prognostic impact of ASXL1 mutation protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing and immunohistochemistry." XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology , Cologne, Germany, p.125.
@conferencepaper{conferencepaper, author={Doğu Vurallı Bakkaloğlu Et Al. }, title={The incidence and prognostic impact of ASXL1 mutation protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing and immunohistochemistry}, congress name={XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology}, city={Cologne}, country={Germany}, year={2016}, pages={125} }